Skip to main content

Peer Review reports

From: Cost-effectiveness of edaravone dexborneol versus dl-3-n-butylphthalide for the treatment of acute ischemic stroke: a Chinese health care perspective

Original Submission
13 Sep 2023 Submitted Original manuscript
31 Oct 2023 Reviewed Reviewer Report
16 Nov 2023 Reviewed Reviewer Report
13 Dec 2023 Author responded Author comments - Pengfei Jin
31 Dec 2023 Author responded Author comments - Pengfei Jin
Resubmission - Version 2
13 Dec 2023 Submitted Manuscript version 2
31 Jan 2024 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
1 Feb 2024 Editorially accepted
12 Feb 2024 Article published 10.1186/s12889-024-17959-3

You can find further information about peer review here.

Back to article page